Market Closed -
Hong Kong S.E.
04:08:20 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
0.83
HKD
|
+2.47%
|
|
0.00%
|
-3.49%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
897.7
|
699.1
|
637.3
|
305.1
|
254.9
|
282
|
Enterprise Value (EV)
1 |
606.1
|
507.5
|
423.1
|
116
|
192.7
|
103.1
|
P/E ratio
|
-1.33
x
|
-18.2
x
|
-4.68
x
|
-0.6
x
|
12.3
x
|
2.46
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
6.85%
|
Capitalization / Revenue
|
0.87
x
|
0.58
x
|
0.61
x
|
0.41
x
|
0.22
x
|
0.25
x
|
EV / Revenue
|
0.59
x
|
0.42
x
|
0.41
x
|
0.16
x
|
0.17
x
|
0.09
x
|
EV / EBITDA
|
-19.2
x
|
87.2
x
|
-10.8
x
|
-4.75
x
|
3.55
x
|
1.99
x
|
EV / FCF
|
260
x
|
-6.46
x
|
5.63
x
|
3.87
x
|
-2.26
x
|
16.3
x
|
FCF Yield
|
0.38%
|
-15.5%
|
17.8%
|
25.8%
|
-44.2%
|
6.13%
|
Price to Book
|
0.78
x
|
0.67
x
|
0.71
x
|
0.72
x
|
0.56
x
|
0.54
x
|
Nbr of stocks (in thousands)
|
383,650
|
386,263
|
386,263
|
386,263
|
386,263
|
386,263
|
Reference price
2 |
2.340
|
1.810
|
1.650
|
0.7900
|
0.6600
|
0.7300
|
Announcement Date
|
4/19/18
|
4/17/19
|
4/27/20
|
4/22/21
|
4/25/22
|
4/25/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
1,028
|
1,196
|
1,041
|
742.6
|
1,153
|
1,144
|
EBITDA
1 |
-31.49
|
5.819
|
-39.27
|
-24.41
|
54.32
|
51.8
|
EBIT
1 |
-223.7
|
-94.89
|
-136.5
|
-115.4
|
39.58
|
25.39
|
Operating Margin
|
-21.75%
|
-7.93%
|
-13.11%
|
-15.55%
|
3.43%
|
2.22%
|
Earnings before Tax (EBT)
1 |
-657.5
|
-25.03
|
-129.3
|
-512.3
|
32.39
|
127.1
|
Net income
1 |
-674.5
|
-38.29
|
-136.3
|
-511.8
|
20.7
|
114.8
|
Net margin
|
-65.61%
|
-3.2%
|
-13.09%
|
-68.92%
|
1.8%
|
10.03%
|
EPS
2 |
-1.758
|
-0.0997
|
-0.3528
|
-1.325
|
0.0536
|
0.2971
|
Free Cash Flow
1 |
2.327
|
-78.58
|
75.12
|
29.96
|
-85.27
|
6.315
|
FCF margin
|
0.23%
|
-6.57%
|
7.22%
|
4.03%
|
-7.4%
|
0.55%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
12.19%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
5.5%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
0.0500
|
Announcement Date
|
4/19/18
|
4/17/19
|
4/27/20
|
4/22/21
|
4/25/22
|
4/25/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
292
|
192
|
214
|
189
|
62.2
|
179
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
2.33
|
-78.6
|
75.1
|
30
|
-85.3
|
6.32
|
ROE (net income / shareholders' equity)
|
-44.5%
|
-3.09%
|
-13.2%
|
-73.4%
|
5.13%
|
20.9%
|
ROA (Net income/ Total Assets)
|
-6.73%
|
-3.7%
|
-5.9%
|
-6.38%
|
2.43%
|
1.43%
|
Assets
1 |
10,020
|
1,034
|
2,310
|
8,028
|
852.4
|
8,006
|
Book Value Per Share
2 |
2.980
|
2.710
|
2.320
|
1.100
|
1.170
|
1.340
|
Cash Flow per Share
2 |
0.6100
|
0.5800
|
0.6300
|
0.5500
|
0.3500
|
0.4900
|
Capex
1 |
142
|
30.6
|
20.1
|
79.2
|
42.6
|
63.6
|
Capex / Sales
|
13.84%
|
2.56%
|
1.93%
|
10.67%
|
3.7%
|
5.56%
|
Announcement Date
|
4/19/18
|
4/17/19
|
4/27/20
|
4/22/21
|
4/25/22
|
4/25/23
|
|
1st Jan change
|
Capi.
|
---|
| -3.49% | 40.95M | | +11.95% | 98.12B | | +9.69% | 38.82B | | -6.10% | 17.66B | | -20.02% | 2.24B | | -8.37% | 1.54B | | +29.63% | 1.23B | | -35.62% | 747M | | -35.36% | 735M | | -13.36% | 623M |
Glasses, Spectacles & Contact Lenses
|